期刊文献+

高血压患者血清8-OHdG变化的研究 被引量:2

Study on 8-OHdG in patients with hypertension
下载PDF
导出
摘要 目的探讨高血压病(essential hypertension,EH)患者血清8-羟基脱氧鸟苷酸(8-hydroxy-deoxyguanosine,8-OHdG)水平的变化。方法选择高血压患者40例,其中轻度高血压患者20例,中度高血压患者20例;健康对照组20例,应用酶联免疫吸附试验检测血清8-OHdG水平。结果轻度高血压患者与对照组相比,中度高血压患者与轻度高血压患者组比较血清8-OHdG浓度升高(P<0.01),而中度高血压患者与对照组比更高(P<0.01)。结论高血压患者存在8-OHdG水平的变化,且与高血压的病情严重程度相关;氧化应激及氧化损伤在中度高血压患者中更明显。 [ Objectives] To investigate the roles of serum 8-hydroxy-2'-deoxyguanosine (8-OHdG) in patients with hypertension. [ Methods ] 40 patients with hypertension and 20 cases with mild hypertension and moderate hypertension were included randomly in this study, and 20 health subjects were included as control group. Serum 8-O- HdG levels of the patients from the 3 groups were measured. [ Results ] The serum levels of 8-OHdG were higher in patients with hypertension when compared with those in control group (P 〈0.01). Moderate hypertension patients were much higher compared with mild hypertension (P 〈0.01). [ Conclusions] Serum 8-OHdG in patients with hypertension would change significantly, and they might correlated with the severity of the disease. In the patients with moderate hypertension, the oxidative stress process would be much more significant.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2012年第1期75-76,79,共3页 China Journal of Modern Medicine
关键词 高血压病 8-羟基脱氧鸟苷酸 氧化应激 hypertension 8-hydroxydeoxyguanosine oxidative stress
  • 相关文献

参考文献3

二级参考文献30

  • 1Puddu P,Puddu GM,Cravero E,et al.The molecular sources of reactive oxygen species in hypertension[J].Blood Press,2008,17(2):70-77.
  • 2Callera GE,Tostes RC,Yogi A,et al.Endothelin-1-induced oxidative stress in DOCA-salt hypertension involves NADPH-oxidase-independent mechanisms[J].Clin Sci(Lond),2006,110(2):243-253.
  • 3Orie NN,Zidek W,Tepel M.Reactive oxygen species in essential hypertension and non-insulin-dependent diabetes mellitus[J].Am J Hypertens,1999,12(12):1169-1174.
  • 4Redon J,Oliva MR,Tormos C,et al.Antioxidant activities and oxidative stress byproducts in human hypertension[J].Hypertension,2003,41(5):1096-1101.
  • 5Saez GT,Tormos C,Giner V,et al.Factors related to the impact of antihypertensive treatment in antioxidant activities and oxidative stress by-products in human hypertension[J].Am J Hypertens,2004,17(9):809-816.
  • 6Simic DV,Mimic-Oka J,Pljesa-Ercegovac M,et al.Byproducts of oxidative protein damage and antioxidant enzyme activities in plasma of patients with different degrees of essential hypertension[J].J Hum Hypertens,2006,20(2):149-155.
  • 7Zhang GX,Kimura S,Nishiyama A,et al.ROS during the acute phase of Ang Ⅱ hypertension participates in cardiovascular MAPK activation but not vasoconstriction[J].Hypertension,2004,43(1):117-124.
  • 8Elmarakby AA,Loomis ED,Pollock JS,et al.NADPH oxidase inhibition attenuates oxidative stress but not hypertension produced by chronic ET-1[J].Hypertension,2005,45(2):283-287.
  • 9Banday AA,Lokhandwala MF.Oxidative stress-induced renal angiotensin AT1receptor upregulation causes increased stimulation of sodium transporters andhypertension[J].Am J Physiol Renal Physiol,2008,295(3):F698-F706.
  • 10Lacy F,Kailasam MT,O′Connor DT,et al.Plasma hydrogen peroxide production in human essential hypertension:role of heredity,gender,and ethnicity[J].Hypertension,2000,36(5):878-884.

共引文献2630

同被引文献18

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部